Cited by 35Metabolomics and Mass Spectrometry StudiesDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort

Open access
Wang, Hao, Wang, Youxin, Li, Xingang, Deng, Xuan, Kong, Yuanyuan, Wang, Wei, Zhou, Yong·2022·Cardiovascular Diabetology

Abstract

Background: Metabolic syndrome (MetS) has been proposed as a clinically identifiable high-risk state for the prediction and prevention of cardiovascular diseases and type 2 diabetes mellitus. As a promising “omics” technology, metabolomics provides an innovative strategy to gain a deeper understanding of the pathophysiology of MetS. The study aimed to systematically investigate the metabolic alterations in MetS and identify biomarker panels for the identification of MetS using machine learning methods. Methods: Nuclear magnetic resonance-based untargeted metabolomics analysis was performed on 1011 plasma samples (205 MetS patients and 806 healthy controls). Univariate and multivariate analyses were applied to identify metabolic biomarkers for MetS. Metabolic pathway enrichment analysis was performed to reveal the disturbed metabolic pathways related to MetS. Four machine learning algorithms, including support vector machine (SVM), random forest (RF), k-nearest neighbor (KNN), and logistic regression were used to build diagnostic models for MetS. Results: Thirteen significantly differential metabolites were identified and pathway enrichment revealed that arginine, proline, and glutathione metabolism are disturbed metabolic pathways related to MetS. The protein-metabolite-disease interaction network identified 38 proteins and 23 diseases are associated with 10 MetS-related metabolites. The areas under the receiver operating characteristic curve of the SVM, RF, KNN, and logistic regression models based on metabolic biomarkers were 0.887, 0.993, 0.914, and 0.755, respectively. Conclusions: The plasma metabolome provides a promising resource of biomarkers for the predictive diagnosis and targeted prevention of MetS. Alterations in amino acid metabolism play significant roles in the pathophysiology of MetS. The biomarker panels and metabolic pathways could be used as preventive targets in dealing with cardiometabolic diseases related to MetS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-022-01716-0

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Traditional medical diagnostics rely heavily on blood sampling, which is invasive and poses discomfort and risks to patients.

    “Traditional medical diagnostics rely heavily on blood sampling to assess metabolite levels and enzyme activities, which, while accurate, is invasive and poses discomfort and risks to patients [5, 6].”

    From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [6]

    The Materials and methods section (Measurements and sample collection; page unavailable) says blood was collected by venipuncture for plasma metabolomics, supporting the blood-sampling and invasive-procedure aspects. It does not say that traditional diagnostics rely heavily on blood sampling or that sampling causes patient discomfort or risks; it also does not address enzyme-activity testing. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [38]Pizzorno J Glutathione! Integr Med 2014 13 1 8 12 PMC4684116 26770075

Cited by

Sorted by citations

Authors
Wang, H., Wang, Y., Li, X., Deng, X., Kong, Y., Wang, W., & Zhou, Y.
Affiliations
  • Capital Medical University (CN)
  • Edith Cowan University (AU)
  • Shanghai Jiao Tong University (CN)
Corresponding author
Zhou, Yong
Venue
Cardiovascular Diabetology
Published
2022-12-23
Volume
21
Issue
1
Pages
288-288
ISSN
1475-2840 (ISSN-L)
OpenAlex
W4312179103
Cited by
34
References
42
Citations by year
2026: 6 · 2025: 16 · 2024: 4 · 2023: 8
FWCI
2.37
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Australasian Journal of Paramedicine (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81973112, 92049302)
  • National Key Research and Development Program of China (2021YFC2500500)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
metabolic syndrome, plasma metabolome, metabolic biomarkers, biomarker panel, arginine metabolism, proline metabolism, glutathione metabolism, amino acid metabolism, metabolic pathway enrichment, diagnostic model, cardiometabolic disease
MeSH terms
Machine Learning, Diabetes Mellitus, Type 2, Humans, Biomarkers, Metabolic Syndrome, Metabolomics, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review